261 related articles for article (PubMed ID: 22154100)
21. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
[TBL] [Abstract][Full Text] [Related]
22. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
23. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
24. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
Vemulapalli V; Yang Y; Friden PM; Banga AK
J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
[TBL] [Abstract][Full Text] [Related]
26. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
27. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
Prasad R; Koul V; Anand S; Khar RK
Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
[TBL] [Abstract][Full Text] [Related]
28. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
29. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
30. Possibility for the development of cosmetics with PLGA nanospheres.
Ito F; Takahashi T; Kanamura K; Kawakami H
Drug Dev Ind Pharm; 2013 May; 39(5):752-61. PubMed ID: 22725249
[TBL] [Abstract][Full Text] [Related]
31. PLGA-based nanoparticles: effect of chitosan in the aggregate stabilization. A dielectric relaxation spectroscopy study.
Chronopoulou L; Cutonilli A; Cametti C; Dentini M; Palocci C
Colloids Surf B Biointerfaces; 2012 Sep; 97():117-23. PubMed ID: 22609591
[TBL] [Abstract][Full Text] [Related]
32. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
33. Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia.
Yadav KS; Jacob S; Sachdeva G; Chuttani K; Mishra AK; Sawant KK
J Microencapsul; 2011; 28(8):729-42. PubMed ID: 21970655
[TBL] [Abstract][Full Text] [Related]
34. A transdermal delivery system to enhance quercetin nanoparticle permeability.
Bennet D; Kim S
J Biomater Sci Polym Ed; 2013; 24(2):185-209. PubMed ID: 23565597
[TBL] [Abstract][Full Text] [Related]
35. In vitro study of transdermal penetration and iontophoresis of hepatitis B vaccines through rat skin.
Xu T; Xu YH; Wei MY; Deng LH; Wu CB
Yao Xue Xue Bao; 2011 Jun; 46(6):713-9. PubMed ID: 21882534
[TBL] [Abstract][Full Text] [Related]
36. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
37. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
38. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin.
Chen H; Zhu H; Zheng J; Mou D; Wan J; Zhang J; Shi T; Zhao Y; Xu H; Yang X
J Control Release; 2009 Oct; 139(1):63-72. PubMed ID: 19481577
[TBL] [Abstract][Full Text] [Related]
39. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
40. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes.
Cheng FY; Wang SP; Su CH; Tsai TL; Wu PC; Shieh DB; Chen JH; Hsieh PC; Yeh CS
Biomaterials; 2008 May; 29(13):2104-12. PubMed ID: 18276001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
